The National Inventors Hall of Fame has named Leroy Hood among its 16 inductees for 2007. Hood, president of the Institute for Systems Biology, was recognized for his role in inventing the automated DNA sequencer, which “has played a crucial role in the biotech industry, greatly accelerating the progress of the Human Genome Project in the 1990s,” according to a statement from the non-profit organization.
Hood has also been elected to the National Academy of Engineering, which named its 64 new members and nine foreign associates last week. The NAE recognized Hood for “the invention and commercialization of key instruments, notably the automated DNA sequencer, that have enabled the biotechnology revolution.”
Gene-IT said last week that it has named Oliver Bayliss to the position of director of European sales.
In the post, Bayliss will help push international sales for the company’s GenomeQuest sequence analysis and searching software.
Bayliss previously served in worldwide sales at BioWisdom and held sales positions at DNAStar, Oxford Molecular, Accelrys, and Viaken.
Erik Wallden has joined the board of directors of VisEn Medical, a developer of fluorescence in vivo imaging technology. Wallden was most recently president and CEO of Biacore International, which was acquired by GE Healthcare last September.
Before joining Biacore in 2004, Wallden was president and CEO of Pyrosequencing. He also held management positions at PerSeptive Biosystems (now Applied Biosystems), Pharmacia Biosensor (now Biacore), and Pharmacia Biotech (now GE Healthcare Life Sciences).
Wallden is currently on the industrial supervisory board of Healthinvest Partners and director of Proxeon and Bergekullen Fastighets.
The Chemical Heritage Foundation said last week that Thomas Cech, Nobel laureate in chemistry, distinguished professor in the department of chemistry and biochemistry at the University of Colorado at Boulder, and president of the Howard Hughes Medical Institute, has been selected to receive the 2007 Othmer Gold Medal, which honors “outstanding individuals who have made multifaceted contributions to our chemical and scientific heritage through outstanding activity in such areas as innovation, entrepreneurship, research, education, public understanding, legislation, or philanthropy.”